Canadian marijuana producer Aurora Cannabis said it received gross proceeds of $172.5 million from a bought deal offering after the underwriters’ over-allotment option was fully exercised.
The bought deal financing was announced last week for $125 million, then upsized to $150 million.
Edmonton, Alberta-based Aurora sold roughly 70.4 million units for $2.45 per unit, including 9.2 million units sold through the over-allotment option, according to a Wednesday news release.
Each unit includes one share and one share purchase warrant exercisable at $3.20 over the next three years.
Net proceeds will be used for general corporate purposes.
The learning curve for entering the cannabis industry is steep. Start with the fundamentals.
MJBiz Cannabis 101 Email Course
A 10-part email course designed to educate new hires and aspiring professionals on the key fundamental areas of the legal cannabis industry, including:
- History of legal cannabis in America
- Overview of plant-touching + ancillary business sectors
- Cannabis finance and investing
- Cannabis marketing and brand building
- Employment + hiring opportunities
- And much more!
Gain a comprehensive understanding of this complex industry with this free resource.
Aurora said in the release that it no longer expects to use its existing at-the-market facility, which still has $186 million outstanding.
Aurora shares trade as ACB on the Nasdaq and Toronto Stock Exchange.